Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Mar-24 5:22 PM View:  | Levin Jeremy M CEO Director | Ovid Therapeutics Inc. (OVID) | 18-Mar-24 | Private Purchase | 18,248 | $2.76 | $50,364.50 | < 1% 3.63M to 3.65M | |
| 26-Feb-24 6:03 PM View: | Rona Jeffrey A CBFO | Ovid Therapeutics Inc. (OVID) | 22-Feb-24 | Grant | 28,125 | -- | -- | 100% 0 to 28.13K | |
| 26-Feb-24 6:05 PM View: | Tardio Jason Chief Operating Officer | Ovid Therapeutics Inc. (OVID) | 22-Feb-24 | Grant | 28,125 | -- | -- | 100% 0 to 28.13K | |
| 26-Feb-24 6:00 PM View: | Perone Thomas Michael General Counsel, Secretary | Ovid Therapeutics Inc. (OVID) | 22-Feb-24 | Grant | 28,125 | -- | -- | 100% 0 to 28.13K | |
| 06-Dec-23 5:05 PM View: | Levin Jeremy M CEO Director | Ovid Therapeutics Inc. (OVID) | 04-Dec-23 | Gift | 1,146,550 | -- | -- | (24%) 4.78M to 3.63M | |
| 14-Sep-22 4:58 PM View: | Tardio Jason Chief Operating Officer | Ovid Therapeutics Inc. (OVID) | 12-Sep-22 | Sale | 17,344 | $2.15 | $37,289.60 | (100%) 17.34K to 0 | |
| 06-Jul-22 6:28 AM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Ovid Therapeutics Inc. (OVID) | 01-Jul-22 | Acquisition (other) | 5,750,000 | -- | -- | 76% 7.53M to 13.28M | |
| 06-Jul-22 6:28 AM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Ovid Therapeutics Inc. (OVID) | 01-Jul-22 | Disposition (other) | 5,750,000 | -- | -- | (43%) 13.28M to 7.53M | |
| 16-Jul-21 6:21 PM View: | Rakhit Amit President and CMO | Ovid Therapeutics Inc. (OVID) | 14-Jul-21 | Market Option Sale | 34,017 | $3.71 | $126,203.00 | (4%) 760.84K to 726.82K | (< 1%) |
| 16-Jul-21 6:21 PM View: | Rakhit Amit President and CMO | Ovid Therapeutics Inc. (OVID) | 14-Jul-21 | Option Exercise | 34,017 | $1.89 | $64,292.10 | 5% 726.82K to 760.84K | |
| 01-Sep-20 9:34 PM View: | Levin Jeremy M CEO Director | Ovid Therapeutics Inc. (OVID) | 28-Aug-20 | Market Purchase | 8,488 | $5.84 | $49,569.90 | < 1% 5.82M to 5.83M | (36%) |
| 22-Nov-19 6:23 AM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Ovid Therapeutics Inc. (OVID) | 08-Oct-19 | Market Purchase | 2,000,000 | $2.50 | $5,000,000.00 | 53% 3.75M to 5.75M | 50% |
| 10-Oct-19 8:32 PM View: | Levin Jeremy M CEO Director | Ovid Therapeutics Inc. (OVID) | 08-Oct-19 | Market Purchase | 60,000 | $2.50 | $150,000.00 | 1% 5.18M to 5.24M | 50% |
| 28-Feb-19 8:15 PM View: | Bernstein Karen Director | Ovid Therapeutics Inc. (OVID) | 26-Feb-19 | Market Purchase | 10,000 | $2.02 | $20,210.00 | 100% 10.0K to 20.0K | 85% |
| 26-Feb-19 10:00 PM View: | Levin Jeremy M CEO Director 10% Owner | Ovid Therapeutics Inc. (OVID) | 22-Feb-19 | Market Purchase | 75,000 | $2.00 | $150,000.00 | 1% 5.1M to 5.18M | 87% |
| 16-Aug-18 9:22 PM View: | Williams Douglas E Director | Ovid Therapeutics Inc. (OVID) | 14-Aug-18 | Market Purchase | 5,000 | $6.49 | $32,441.50 | 100% 0 to 5.0K | (43%) |
| 16-Aug-18 9:24 PM View: | Bernstein Karen Director | Ovid Therapeutics Inc. (OVID) | 14-Aug-18 | Market Purchase | 10,000 | $6.23 | $62,300.00 | 100% 0 to 10.0K | (40%) |
| 28-Aug-17 6:29 PM View: | Levin Jeremy M CEO Director 10% Owner | Ovid Therapeutics Inc. (OVID) | 25-Aug-17 | Market Purchase | 15,334 | $7.15 | $109,638.00 | < 1% 5.09M to 5.1M | (48%) |
| 10-May-17 5:14 PM View: | During Matthew President and CSO Director 10% Owner | Ovid Therapeutics Inc. (OVID) | 10-May-17 | Conversion | 28,245 | -- | -- | < 1% 4.65M to 4.68M | |
| 10-May-17 5:16 PM View: | Levin Jeremy M CEO Director 10% Owner | Ovid Therapeutics Inc. (OVID) | 10-May-17 | Conversion | 400,150 | -- | -- | 9% 4.65M to 5.05M | |
| 10-May-17 5:16 PM View: | Levin Jeremy M CEO Director 10% Owner | Ovid Therapeutics Inc. (OVID) | 10-May-17 | Conversion | 35,461 | -- | -- | < 1% 5.05M to 5.09M |
